Views & Analysis Healthcare’s hype cycle: which technologies will stay the co... Where should pharma invest to remain at the forefront of healthcare?
Articles Digital health round-up: Philips' IoT, bioprinting and more A round-up of this week's top digital healthcare news. Marco Ricci reports.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
